Walgreens to Pay $300 Million in U.S. Opioid Settlement

Walgreens has agreed to a $300 million settlement over allegations it filled invalid opioid prescriptions. This agreement is part of a larger wave of legal resolutions tied to the opioid epidemic.

Published on
Read : 2 min
Walgreens store
Walgreens to Pay $300 Million in U.S. Opioid Settlement | en.Econostrum.info - United States

Walgreens has reached a significant settlement agreement with U.S. prosecutors, agreeing to pay $300 million to resolve allegations that it unlawfully filled millions of opioid prescriptions. This settlement is part of an ongoing effort by various companies to address their role in the opioid epidemic, which has had devastating effects on communities across the United States.

According to NBC News, the settlement highlights the increasing financial and legal pressures on corporations involved in the opioid crisis. Walgreens’ agreement also reflects a larger trend of pharmaceutical companies facing scrutiny and paying settlements to resolve lawsuits related to opioid misuse.

The Terms of the Settlement

Under the terms of the settlement, Walgreens will pay $300 million over six years, plus 4% annual interest. In addition, the company will owe another $50 million if it is sold, merged, or transferred before fiscal year 2032.

This agreement follows a January lawsuit where the government accused Walgreens of ignoring “red flags” indicating that prescriptions were fraudulent, yet the company continued to fill them, which is a violation of the Controlled Substances Act.

While Walgreens has agreed to this settlement, the company has maintained its position that it does not admit to any legal wrongdoing. A company spokesperson, Fraser Engerman, stated,

We strongly disagree with the government’s legal theory and admit no liability. Our pharmacists are dedicated healthcare professionals who care deeply about patient safety and continue to play a critical role in providing education and resources to help combat opioid misuse and abuse across our country.

Despite this settlement, Walgreens has also noted that it does not foresee any major cases related to opioids in the future.

The Broader Opioid Settlement Landscape

This settlement is part of a larger movement in which various companies, including drug manufacturers and distributors, have paid billions of dollars to resolve lawsuits linked to the opioid crisis.

In 2022, Walgreens itself agreed to pay up to $5.52 billion over 15 years to settle thousands of state and local lawsuits accusing it of helping to fuel the opioid epidemic.

The opioid epidemic continues to devastate communities across the U.S., with nearly 727,000 opioid overdose deaths reported between 1999 and 2022, according to the Centers for Disease Control and Prevention (CDC).

Leave a Comment

Share to...